| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |